Table E1.
Variable | Overall, n (%) | No TV operation, n (%) | Concomitant TV operation, n (%) |
---|---|---|---|
Age | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Female sex | 0 (0.0) | 0 (0.0) | 0 (0.0) |
BMI (kg/m2) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Race | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Mitral etiology | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Mitral regurgitation | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Mitral stenosis | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Tricuspid etiology | 0 (0.0) | 0 (0.0) | 0 (0.0) |
LVEF (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
PASP (mm Hg) | 36 (17.1) | 25 (17.5) | 11 (16.4) |
NYHA class 3 or 4 | 2 (1.0) | 2 (1.4) | 0 (0.0) |
Comorbidities | |||
Hypertension | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Atrial fibrillation | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Chronic lung disease | 1 (0.5) | 1 (0.7) | 0 (0.0) |
Diabetes | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Dialysis | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Prior cardiac intervention | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Prior mitral surgery | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Prior TV surgery | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Prior CABG | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Prior PCI | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Prior PPM | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Laboratory values | |||
Creatinine (mg/dL) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
WBC count (109/L) | 1 (0.5) | 1 (0.7) | 0 (0.0) |
Hematocrit (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
TV, Tricuspid valve; BMI, body mass index; LVEF, left ventricular ejection fraction; PASP, pulmonary artery systolic pressure; NYHA, New York Heart Association; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; PPM, permanent pacemaker placement; WBC, white blood cell.